Compare CATY & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CATY | TXG |
|---|---|---|
| Founded | 1962 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.6B |
| IPO Year | 1996 | 2019 |
| Metric | CATY | TXG |
|---|---|---|
| Price | $60.98 | $28.84 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 15 |
| Target Price | ★ $52.50 | $20.25 |
| AVG Volume (30 Days) | 333.5K | ★ 3.0M |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.77% | N/A |
| EPS Growth | 14.94 | ★ 76.97 |
| EPS | ★ 1.29 | N/A |
| Revenue | $53,793,000.00 | ★ $245,893,000.00 |
| Revenue This Year | $20.37 | N/A |
| Revenue Next Year | $5.41 | $7.33 |
| P/E Ratio | $46.44 | ★ N/A |
| Revenue Growth | 2.93 | ★ 68.06 |
| 52 Week Low | $42.07 | $10.17 |
| 52 Week High | $60.12 | $35.65 |
| Indicator | CATY | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 69.30 | 57.46 |
| Support Level | $55.67 | $16.11 |
| Resistance Level | N/A | $35.65 |
| Average True Range (ATR) | 1.06 | 2.31 |
| MACD | 0.20 | -0.09 |
| Stochastic Oscillator | 98.94 | 46.81 |
Cathay General Bancorp is a regional bank predominantly serving the Chinese-American community. The company's policy is to reach out and actively offer services to low-to-moderate income groups in the delineated branch service areas. It predominantly provides services such as checking and deposit, lines of credit, commercial and commercial real estate loans, merchant services and payment processing, treasury management services, international banking and financing services, and other customary banking services to individuals, professionals, and small to medium-sized businesses. Through its Wealth Management unit, the company also offers investment products and services, such as stocks, bonds, mutual funds, insurance, annuities, and advisory services.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).